Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Healthcare | 9.78% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Liquidity Services
LQDT
$1.36B
| $2.74M | ﹤0.01% |
147,282
+24,408
| +20% | +$442K |
|
3927
Photronics
PLAB
$1.96B
| $2.74M | ﹤0.01% |
212,837
+5,931
| +3% | +$71.8K |
|
3928
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$968M
| $2.73M | ﹤0.01% |
184,681
+54,780
| +42% | +$880K |
|
3929
BlackRock MuniAssets Fund
MUA
$521M
| $2.73M | ﹤0.01% |
178,792
+29,551
| +20% | +$441K |
|
3930
Enliven Therapeutics
ELVN
$4.31B
| $2.72M | ﹤0.01% |
80,582
+78,531
| +3,829% | +$3.99M |
|
|
THER
3931
DELISTED
THERATECHNOLOGIES INC COM
THER
| $2.72M | ﹤0.01% |
703,735
+299,865
| +74% | +$1.16M |
|
|
CHCT
3932
Community Healthcare Trust
CHCT
$432M
| $2.72M | ﹤0.01% |
58,950
-11,479
| -16% | -$533K |
|
3933
WesBanco
WSBC
$4.09B
| $2.72M | ﹤0.01% |
75,291
+7,438
| +11% | +$245K |
|
3934
Universal Electronics
UEIC
$67.9M
| $2.71M | ﹤0.01% |
49,394
+4,102
| +9% | +$237K |
|
3935
XPEL
XPEL
$1.38B
| $2.71M | ﹤0.01% |
52,283
+28,451
| +119% | +$1.53M |
|
3936
Minerva Neurosciences
NERV
$219M
| $2.71M | ﹤0.01% |
116,147
+55,731
| +92% | +$1.39M |
|
3937
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$89.8M
| $2.71M | ﹤0.01% |
71,626
-35,372
| -33% | -$1.35M |
|
|
CMD
3938
DELISTED
Cantel Medical Corporation
CMD
| $2.71M | ﹤0.01% |
33,970
-47,824
| -58% | -$3.73M |
|
3939
RE/MAX Holdings
RMAX
$268M
| $2.71M | ﹤0.01% |
68,646
-81,591
| -54% | -$3.2M |
|
3940
Xtrackers S&P 500 ESG ETF
SNPE
$2.79B
| $2.71M | ﹤0.01% |
77,786
+49,331
| +173% | +$1.67M |
|
3941
Inovio Pharmaceuticals
INO
$113M
| $2.7M | ﹤0.01% |
24,216
-23,874
| -50% | -$3.14M |
|
|
NEV
3942
DELISTED
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
| $2.69M | ﹤0.01% |
160,504
-7,608
| -5% | -$122K |
|
|
DSM
3943
BNY Mellon Strategic Municipal Bond Fund
DSM
$290M
| $2.69M | ﹤0.01% |
343,807
+4,694
| +1% | +$36.7K |
|
3944
OraSure Technologies
OSUR
$265M
| $2.69M | ﹤0.01% |
230,215
-58,205
| -20% | -$713K |
|
|
KE
3945
Kimball Electronics
KE
$622M
| $2.69M | ﹤0.01% |
104,103
+1,871
| +2% | +$42.6K |
|
|
ONCR
3946
DELISTED
Oncorus, Inc.
ONCR
| $2.69M | ﹤0.01% |
192,898
+185,768
| +2,605% | +$3.85M |
|
|
JTD
3947
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $2.69M | ﹤0.01% |
177,702
-91,231
| -34% | -$1.32M |
|
3948
Airgain
AIRG
$72.2M
| $2.68M | ﹤0.01% |
126,448
+66,464
| +111% | +$1.5M |
|
3949
Imunon
IMNN
$9.26M
| $2.68M | ﹤0.01% |
9,927
+9,871
| +17,627% | +$3.32M |
|
|
EVRI
3950
DELISTED
Everi Holdings
EVRI
| $2.68M | ﹤0.01% |
189,860
-80,405
| -30% | -$1.14M |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 188 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 188 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.